Crossmark

Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry

Crossref DOI link: https://doi.org/10.1007/s00392-019-01517-8

Published Online: 2019-06-29

Published Print: 2020-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huseynov, Aydin

Baumann, Stefan

Nef, Holger

Riemer, Thomas

Schneider, Steffen

Pfannenbecker, Thomas

Achenbach, Stephan

Mehilli, Julinda

Münzel, Thomas

Gori, Tommaso

Wöhrle, Jochen

Zahn, Ralf

Kastner, Johannes

Schmermund, Axel

Richardt, Gert

Hamm, Christian W.

Akin, Ibrahim
License Information

Text and Data Mining valid from 2019-06-29

Version of Record valid from 2019-06-29
More Information

Article History

Received: 27 February 2019

Accepted: 24 June 2019

First Online: 29 June 2019

Compliance with ethical standards

:

: All other authors declare no conflict of interest.

Document is current

Any future updates will be listed below